Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes

NCT02345239 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Pantoprazole

Sponsor

Dr. Waheed Rehman